Manages edema and sodium retention. ANDA 86513, held by Mylan. Hydrochlorothiazide; Spironolactone.
As of Nov 16, 2026, ANDA 86513 (Spironolactone And Hydrochlorothiazide), held by Mylan, was first approved by FDA on Aug 3, 1979, with 23 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Spironolactone, an ingredient of spironolactone and hydrochlorothiazide tablets, has been shown to be a tumorigen in chronic toxicity studies in rats (see Precautions section). Spironolactone and hydrochlorothiazide tablets should be used only in those conditions described below. Unnecessary use of this drug should be avoided.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 3, 1979 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Spironolactone And Hydrochlorothiazide25MG;25MG · tablet;oral | Hydrochlorothiazide; Spironolactone | Rx |
| Apr 20, 2023 | Supplement 86Labeling · Standard review | Approved | None posted |
| Apr 20, 2023 | Supplement 82Labeling · Standard review | Approved | None posted |
| Apr 20, 2023 | Supplement 80Labeling · Standard review | Approved | None posted |
| Feb 17, 2023 | Supplement 84Manufacturing | Approved | None posted |
| Nov 6, 2019 | Supplement 76Labeling · Standard review | Approved | None posted |
| Jun 14, 2016 | Supplement 75Manufacturing | Approved | None posted |
| Jan 5, 2016 | Supplement 73Labeling · Standard review | Approved | None posted |
| Feb 5, 2013 | Supplement 68Labeling · Standard review | Approved | None posted |
| Jun 3, 2002 | Supplement 53Manufacturing | Approved | None posted |
| Sep 5, 2001 | Supplement 52Manufacturing | Approved | None posted |
| Apr 21, 2000 | Supplement 50Manufacturing | Approved | None posted |
| Mar 27, 2000 | Supplement 51Labeling | Approved | None posted |
| Dec 1, 1999 | Supplement 49Labeling | Approved | None posted |
| Aug 26, 1998 | Supplement 48Labeling | Approved | None posted |
| Feb 25, 1998 | Supplement 46Manufacturing | Approved | None posted |
| Feb 5, 1998 | Supplement 47Manufacturing | Approved | None posted |
| Dec 17, 1993 | Supplement 45Manufacturing | Approved | None posted |
| Jun 9, 1993 | Supplement 43Labeling | Approved | None posted |
| May 30, 1991 | Supplement 42Labeling | Approved | None posted |
| Apr 4, 1990 | Supplement 41Labeling | Approved | None posted |
| Jan 31, 1990 | Supplement 38Manufacturing | Approved | None posted |
| Sep 18, 1984 | Supplement 33Manufacturing | Approved | None posted |
| Mar 18, 1982 | Supplement 30Manufacturing | Approved | None posted |
| Aug 3, 1979 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters